|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-20
|
|
pubmed:abstractText |
a) To evaluate in septic patients the blood levels of endocan, a circulating proteoglycan, which regulates leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interactions in vitro; b) to determine whether endocan could be used as a diagnostic and prognostic marker in sepsis in the intensive care unit; and c) to study kinetics of endocan secretion by endothelial cells in vitro after stimulation by soluble mediators involved in sepsis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
532-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16424738-Biological Markers,
pubmed-meshheading:16424738-Case-Control Studies,
pubmed-meshheading:16424738-Female,
pubmed-meshheading:16424738-Humans,
pubmed-meshheading:16424738-Male,
pubmed-meshheading:16424738-Middle Aged,
pubmed-meshheading:16424738-Neoplasm Proteins,
pubmed-meshheading:16424738-Prognosis,
pubmed-meshheading:16424738-Proteoglycans,
pubmed-meshheading:16424738-Sepsis,
pubmed-meshheading:16424738-Severity of Illness Index,
pubmed-meshheading:16424738-Shock, Septic
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Endocan, a new endothelial marker in human sepsis.
|
|
pubmed:affiliation |
INSERM Unit 416, Institut Pasteur de Lille, France. a-scherpereel@chru-lille.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
